Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|May 10, 2022
Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody ResponsesLaila Sara Arroyo Mühr, Carina Eklund, Camilla Lagheden, et al.
Human Vaccines & Immunotherapeutics|December 13, 2019
Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 yearsDan Bi, Dan Apter, Tiina Eriksson, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|June 18, 2013
Impact of HPV16/18 vaccination on quality of life: a pilot studyTiina Eriksson, Saku Torvinen, Sarah C Woodhall, et al.
International Journal of Cancer|June 24, 2020
Long-term follow-up of human papillomavirus type replacement among young pregnant Finnish females before and after a community-randomised HPV vaccination trial with moderate coveragePenelope Gray, Hanna Kann, Ville N Pimenoff, et al.
International Journal of Cancer|November 19, 2019
Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females-Results from a community-randomized trialMatti Lehtinen, Dan Apter, Tiina Eriksson, et al.
Plos Medicine|June 7, 2021
Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trialPenelope Gray, Hanna Kann, Ville N Pimenoff, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 18, 2024
The quality of life of frequently vs. infrequently screened HPV vaccinated womenKaisa Taavela, Tiina Eriksson, Heini Huhtala, et al.
Open Forum Infectious Diseases|April 14, 2026
Protective Human Papillomavirus Type 16/18 Vaccine-Induced Neutralizing Antibody Levels Remain ElusiveMatti Lehtinen, Tiina Eriksson, Tiina Petäjä, et al.
International Journal of Cancer|February 6, 2019
Occurrence of human papillomavirus (HPV) type replacement by sexual risk-taking behaviour group: Post-hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV)Penelope Gray, Tapio Luostarinen, Simopekka Vänskä, et al.
Plos One|July 11, 2024
Seroepidemiological assessment of the spread of SARS-CoV-2 among 25 and 28 year-old adult women in Finland between March 2020-June 2022Penelope Gray, Tiina Eriksson, Lovisa Skoglund, et al.
Pageof 5